Physicians Financial Services’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.23M | Buy |
5,192
+222
| +4% | +$227K | 1.55% | 13 |
|
|
2026
Q1 | $4.57M | Buy |
4,970
+872
| +21% | +$884K | 1.25% | 23 |
|
|
2025
Q4 | $4.4M | Buy |
4,098
+102
| +3% | +$97.5K | 1.18% | 23 |
|
|
2025
Q3 | $3.05M | Buy |
3,996
+81
| +2% | +$60.3K | 0.83% | 28 |
|
|
2025
Q2 | $3.05M | Buy |
3,915
+308
| +9% | +$239K | 0.91% | 29 |
|
|
2025
Q1 | $2.98M | Buy |
3,607
+570
| +19% | +$474K | 0.95% | 28 |
|
|
2024
Q4 | $2.35M | Buy |
3,037
+8
| +0.3% | +$6.62K | 0.71% | 31 |
|
|
2024
Q3 | $2.68M | Buy |
3,029
+165
| +6% | +$148K | 0.83% | 31 |
|
|
2024
Q2 | $2.59M | Buy |
2,864
+51
| +2% | +$40.8K | 0.84% | 31 |
|
|
2024
Q1 | $2.19M | Buy |
2,813
+60
| +2% | +$42.7K | 0.77% | 32 |
|
|
2023
Q4 | $1.6M | Buy |
2,753
+25
| +0.9% | +$14.6K | 0.61% | 40 |
|
|
2023
Q3 | $1.47M | Buy |
2,728
+10
| +0.4% | +$5.15K | 0.6% | 44 |
|
|
2023
Q2 | $1.27M | Buy |
2,718
+50
| +2% | +$21K | 0.5% | 51 |
|
|
2023
Q1 | $916K | Hold |
2,668
| – | – | 0.39% | 62 |
|
|
2022
Q4 | $976K | Hold |
2,668
| – | – | 0.44% | 61 |
|
|
2022
Q3 | $863K | Hold |
2,668
| – | – | 0.42% | 60 |
|
|
2022
Q2 | $865K | Hold |
2,668
| – | – | 0.38% | 60 |
|
|
2022
Q1 | $764K | Hold |
2,668
| – | – | 0.29% | 69 |
|
|
2021
Q4 | $737K | Hold |
2,668
| – | – | 0.27% | 71 |
|
|
2021
Q3 | $616K | Hold |
2,668
| – | – | 0.25% | 73 |
|
|
2021
Q2 | $612K | Sell |
2,668
-237
| -8% | -$47.6K | 0.25% | 72 |
|
|
2021
Q1 | $543K | Buy |
2,905
+137
| +5% | +$26.8K | 0.23% | 75 |
|
|
2020
Q4 | $467K | Hold |
2,768
| – | – | 0.23% | 75 |
|
|
2020
Q3 | $410K | Hold |
2,768
| – | – | 0.2% | 78 |
|
|
2020
Q2 | $454K | Hold |
2,768
| – | – | 0.25% | 73 |
|
|
2020
Q1 | $384K | Hold |
2,768
| – | – | 0.26% | 76 |
|
|
2019
Q4 | $364K | Hold |
2,768
| – | – | 0.2% | 89 |
|
|
2019
Q3 | $310K | Hold |
2,768
| – | – | 0.18% | 97 |
|
|
2019
Q2 | $307K | Sell |
2,768
-270
| -9% | -$31.8K | 0.18% | 99 |
|
|
2019
Q1 | $394K | Hold |
3,038
| – | – | 0.24% | 88 |
|
|
2018
Q4 | $352K | Buy |
+3,038
| New | +$339K | 0.26% | 85 |
|
|
2017
Q1 | – | Sell |
-1,738
| Closed | -$145K | – | 203 |
|
|
2016
Q4 | $145K | Hold |
1,738
| – | – | 0.12% | 122 |
|
|
2016
Q3 | $139K | Buy |
1,738
+100
| +6% | +$8K | 0.12% | 121 |
|
|
2016
Q2 | $129K | Buy |
1,638
+165
| +11% | +$12.4K | 0.11% | 123 |
|
|
2016
Q1 | $106K | Hold |
1,473
| – | – | 0.1% | 128 |
|
|
2015
Q4 | $124K | Buy |
+1,473
| New | +$122K | 0.11% | 130 |
|
Other funds holding LLY
SC
ONB
GIM
Physicians Financial Services's LLY Position: Q2 2026 in Review
Physicians Financial Services increased its Eli Lilly (LLY) stake by 4.5% in Q2 2026, buying an estimated $227K and bringing the position to 5,192 shares worth $6.23M. The position accounts for 1.55% of the portfolio, ranked #13.
Physicians Financial Services first reported a position in LLY in Q4 2015 and has held it in 36 quarters since. 1,692 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Physicians Financial Services held 5,192 shares of Eli Lilly worth $6.23M as of Q2 2026.
- Physicians Financial Services bought 222 Eli Lilly shares in Q2 2026, an estimated $227K.
- Eli Lilly made up 1.55% of Physicians Financial Services's portfolio in Q2 2026, its #13 holding.
- Physicians Financial Services first reported a position in Eli Lilly in Q4 2015 and has held it in 36 quarters since.
- 1,692 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Physicians Financial Services's 13F filing for Q2 2026, filed 21 Jul 2026.